Skip to main content

4 Result(s)

within Vineet Punia Remove this filter

and

  1. Article

    Open Access

    Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

    ELEVATE (Study 410; NCT03288129) is the first prospective, multicenter, open-label, Phase IV study of perampanel as monotherapy or first adjunctive therapy in patients aged ≥ 4 years with focal-onset seizures ...

    Vineet Punia, Pavel Klein, Temenuzhka Mihaylova, Victor Biton… in Journal of Neurology (2024)

    Download PDF (773 KB) View Article

  2. Article

    Open Access

    SARS-CoV-2 alters neural synchronies in the brain with more severe effects in younger individuals

    Coronavirus disease secondary to infection by SARS-CoV-2 (COVID19 or C19) causes respiratory illness, as well as severe neurological symptoms that have not been fully characterized. In a previous study, we dev...

    Helen Valsamis, Samah Abdul Baki, Jason Leung, Samer Ghosn… in Scientific Reports (2023)

    Download PDF (2252 KB) View Article

  3. Article

    Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: Is There an Association?

    The coronavirus disease of 2019 (COVID-19) emerged as a global pandemic. Historically, the group of human coronaviruses can also affect the central nervous system leading to neurological symptoms; however, the...

    Madihah Hepburn, Naresh Mullaguri, Pravin George, Stephen Hantus… in Neurocritical Care (2021)

    Download PDF (1295 KB) View Article

  4. No Access

    Article

    Post-treatment T1 shortening in primary CNS lymphoma

    The incidence of primary central nervous system lymphoma (PCNSL) has increased over the past two decades. The MR imaging appearance of PCNSL plays a central role in the initial diagnosis, management and follow...

    Sasan Karimi, Vaios Hatzoglou, Vineet Punia, Sasan Partovi… in Journal of Neuro-Oncology (2013)